Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Learn when mutual funds can be preferable to index funds, considering objectives, risk tolerance, and horizon. Make informed allocation decisions.
25,127 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Crypto traders are pricing SpaceX ahead of any IPO using Hyperliquid's SPCX-USDC contract, with early data suggesting...
In a high-rate environment, Verizon’s steady cash flow and dividend attract institutional buyers. Here’s why it’s gai...
Anthropic is moving toward a public listing, with Amazon and Google as key backers. If the IPO hits a trillion-dollar...
A veteran hedge-fund manager behind an early SpaceX investment argues the AI-driven bottleneck trade is fading, trigg...
Bitcoin weakness tracks chip-stock pressure as Nvidia falls and the ETH Foundation trims staff. Traders brace for rat...
A fresh memory company touts a coiled-spring architecture to outpace NAND rivals amid AI-driven demand, sparking a co...
PayPal’s PYUSD has moved onto Polygon, issued by Paxos, enabling cross-border payments with built-in compliance and d...
South Korea is accelerating its digital won experiment, moving from a controlled test to a broader rollout. This arti...
Bitdeer, a leading Bitcoin miner, has sold its entire BTC stash, signaling a strategic pivot that could influence nea...
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...